Brant T Bennett
Examiner (ID: 9315)
Most Active Art Unit | 3786 |
Art Unit(s) | 3786 |
Total Applications | 35 |
Issued Applications | 11 |
Pending Applications | 0 |
Abandoned Applications | 24 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16563488
[patent_doc_number] => 10888841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Affinity chromatography carrier and method for purifying biological substance
[patent_app_type] => utility
[patent_app_number] => 15/952627
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14542
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952627 | Affinity chromatography carrier and method for purifying biological substance | Apr 12, 2018 | Issued |
Array
(
[id] => 15102643
[patent_doc_number] => 10472623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Antigen-binding molecule capable of binding two or more antigen molecules repeatedly
[patent_app_type] => utility
[patent_app_number] => 15/952945
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 47072
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952945
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/952945 | Antigen-binding molecule capable of binding two or more antigen molecules repeatedly | Apr 12, 2018 | Issued |
Array
(
[id] => 13986523
[patent_doc_number] => 20190062419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => PROTEIN PURIFICATION METHODS TO REDUCE ACIDIC SPECIES
[patent_app_type] => utility
[patent_app_number] => 15/951560
[patent_app_country] => US
[patent_app_date] => 2018-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15951560
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/951560 | PROTEIN PURIFICATION METHODS TO REDUCE ACIDIC SPECIES | Apr 11, 2018 | Abandoned |
Array
(
[id] => 17236664
[patent_doc_number] => 11180536
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Antibodies to royalactin and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/604123
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 9143
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604123
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604123 | Antibodies to royalactin and uses thereof | Apr 10, 2018 | Issued |
Array
(
[id] => 13479033
[patent_doc_number] => 20180291059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => IMMUNOAFFINITY PURIFICATION OF ANTIBODIES USING MIMETOPES
[patent_app_type] => utility
[patent_app_number] => 15/944099
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944099
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/944099 | IMMUNOAFFINITY PURIFICATION OF ANTIBODIES USING MIMETOPES | Apr 2, 2018 | Abandoned |
Array
(
[id] => 15438359
[patent_doc_number] => 20200033363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => SCREENING METHODS
[patent_app_type] => utility
[patent_app_number] => 16/497788
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16497788
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/497788 | SCREENING METHODS | Mar 26, 2018 | Abandoned |
Array
(
[id] => 16681712
[patent_doc_number] => 10941178
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Method of purifying an antibody
[patent_app_type] => utility
[patent_app_number] => 15/924163
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24241
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15924163
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/924163 | Method of purifying an antibody | Mar 15, 2018 | Issued |
Array
(
[id] => 16680942
[patent_doc_number] => 10940401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Method for chromatography reuse
[patent_app_type] => utility
[patent_app_number] => 15/920237
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 41
[patent_no_of_words] => 36709
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/920237 | Method for chromatography reuse | Mar 12, 2018 | Issued |
Array
(
[id] => 16642094
[patent_doc_number] => 10919930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-16
[patent_title] => Enhanced purification of antibodies and antibody fragments by apatite chromatography
[patent_app_type] => utility
[patent_app_number] => 15/910702
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9782
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15910702
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/910702 | Enhanced purification of antibodies and antibody fragments by apatite chromatography | Mar 1, 2018 | Issued |
Array
(
[id] => 12885070
[patent_doc_number] => 20180186865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Method for the reduction of host cell proteins in affinity chromatography
[patent_app_type] => utility
[patent_app_number] => 15/900443
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900443
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900443 | Method for the reduction of host cell proteins in affinity chromatography | Feb 19, 2018 | Abandoned |
Array
(
[id] => 12884971
[patent_doc_number] => 20180186832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Method for the reduction of host cell proteins in affinity chromatography
[patent_app_type] => utility
[patent_app_number] => 15/900461
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900461
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900461 | Method for the reduction of host cell proteins in affinity chromatography | Feb 19, 2018 | Abandoned |
Array
(
[id] => 12885073
[patent_doc_number] => 20180186866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => AFFINITY CHROMATOGRAPHY PURIFICATION WITH LOW CONDUCTIVITY WASH BUFFER
[patent_app_type] => utility
[patent_app_number] => 15/900449
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900449
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900449 | AFFINITY CHROMATOGRAPHY PURIFICATION WITH LOW CONDUCTIVITY WASH BUFFER | Feb 19, 2018 | Abandoned |
Array
(
[id] => 13567777
[patent_doc_number] => 20180335436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => Diagnostics and Therapeutics for Macular Degeneration-Related Disorders
[patent_app_type] => utility
[patent_app_number] => 15/897609
[patent_app_country] => US
[patent_app_date] => 2018-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25127
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897609
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/897609 | Diagnostics and Therapeutics for Macular Degeneration-Related Disorders | Feb 14, 2018 | Abandoned |
Array
(
[id] => 14712993
[patent_doc_number] => 20190247560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => EXTRACORPOREAL DEVICES AND METHODS OF TREATING COMPLEMENT FACTOR RELATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/895551
[patent_app_country] => US
[patent_app_date] => 2018-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22920
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15895551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/895551 | EXTRACORPOREAL DEVICES AND METHODS OF TREATING COMPLEMENT FACTOR RELATED DISEASES | Feb 12, 2018 | Pending |
Array
(
[id] => 18172705
[patent_doc_number] => 11572402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-07
[patent_title] => Method for promoting diversification of antibody variable region
[patent_app_type] => utility
[patent_app_number] => 16/484061
[patent_app_country] => US
[patent_app_date] => 2018-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 10279
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484061 | Method for promoting diversification of antibody variable region | Feb 8, 2018 | Issued |
Array
(
[id] => 12837400
[patent_doc_number] => 20180170973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN
[patent_app_type] => utility
[patent_app_number] => 15/887381
[patent_app_country] => US
[patent_app_date] => 2018-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15887381
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/887381 | IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN | Feb 1, 2018 | Abandoned |
Array
(
[id] => 13328597
[patent_doc_number] => 20180215836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN
[patent_app_type] => utility
[patent_app_number] => 15/883569
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883569
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/883569 | IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN | Jan 29, 2018 | Abandoned |
Array
(
[id] => 13328515
[patent_doc_number] => 20180215795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY-BINDING CAPACITY IN ACIDIC pH REGIONS
[patent_app_type] => utility
[patent_app_number] => 15/876597
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11737
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876597 | ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY-BINDING CAPACITY IN ACIDIC pH REGIONS | Jan 21, 2018 | Abandoned |
Array
(
[id] => 13328595
[patent_doc_number] => 20180215835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY-BINDING CAPACITY IN ACIDIC pH REGION
[patent_app_type] => utility
[patent_app_number] => 15/876604
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876604 | ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY-BINDING CAPACITY IN ACIDIC pH REGION | Jan 21, 2018 | Abandoned |
Array
(
[id] => 13328517
[patent_doc_number] => 20180215796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY BINDING CAPACITY IN ACIDIC pH REGION
[patent_app_type] => utility
[patent_app_number] => 15/876610
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11305
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876610 | ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY BINDING CAPACITY IN ACIDIC pH REGION | Jan 21, 2018 | Abandoned |